Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents

The company completed enrollment in a study intended to support an anticipated indication expansion for its Swoop system when used with contrast agents. The milestone advances the potential regulatory and commercial expansion of the medical-imaging product, though no clinical results, timing, or financial impact were disclosed.